维普期刊资源整合服务平台（V6.5）

162篇 您的检索式：作者名="Burger RA"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Value of preoperative CA125 level in the management of uterine cancer and prediction of clinical outcome显示文摘	Sood AK Buller RE Burger RA	1997	Obstet Gynecol1997，90，3：	1
2	Phase Ⅱ trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study显示文摘	Burger RA Sill MW Monk B J	2007	J Clin Oncol2007，25，33：	1
3	Bowel resection at the time of primary cytoreduction for epithelial ovarian cancer 显示文摘	Gillette-Cloven N Burger RA Monk BJ	2001	J Am Coll Surg2001，193，6：	1
4	Spontaneous release of inter Ieukin-6 by primary cultures of Iymphoid and tumor cell populations purified from humano verrian carvinoma显示文摘	Burger RA Grosen EA Ioli GR	1995	J I nterferon cytokine Research1995，15，3：	1
5	Predicting short-term urina- ry retention after vaginal prolapse surgery显示文摘	Hakvoort RA DijkgraafMG Burger MP	2009	Neurourol Urodyn2009，28，3：	1
6	Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer:, a systematic review 显示文摘	Gerestein CG Damhuis RA Burger CW	2009	Gynecol Oncol2009，114，3：	1
7	Prognostic factors in neuroendocrine small cell cervical carcinoma:a multivariate analysis显示文摘	Chan JK Loizzi V Burger RA	2003	Cancer2003，97，3：	1
8	Incorporation of bevacizumab in the primary treatment of ovarian cancer 显示文摘	Burger RA Brady MF Bookman MA	2011	N Engl JMed2011，365，26：	1
9	Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies 显示文摘	Burger RA	2010	J Gynecol Oncol2010，21，1：	1
10	Human papillomavirus type 18: Association with poor prognosis in early stage cervical cancer 显示文摘	Burger RA Monk B J Kurosaki T	1996	J Natl Cancer Inst1996，88，19：	1
11	Overview of anti-angiogenie agents in develop- ment for ovarian cancer显示文摘	Burger RA	2011	Gynecologic Oncology2011，121，1：	1
12	Early stage cervical cancers containing human papillomavirus type 15 DNA have more nodal metastasis and deeper stromal invasion 显示文摘	Im SS Wilczynski SP Burger RA	2003	Clin Cancer Res2003，9，11：	1
13	Prognostic factors inneuroendocrine small cell cervical carcinoma: a multivariate analysis 显示文摘	Chan JK Loizzi V Burger RA	2003	Cancer2003，97，3：	1
14	Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis 显示文摘	Chan JK Loizzi V Burger RA	2003	Cancer2003，97，3：	1
15	Incorporation of bevacizumab in the primary treatment of ovarian cancer显示文摘	Burger RA Brady MF Bookman MA	2011	New Engl J Med2011，365，26：	1
16	Patient preferences for clean intermittent catheterisation and transurethral indwelling eathe- terisation for treatment of abnormal post-void residual bladder volu- me after vaginal prolapse surgery显示文摘	Hakvoort RA Nieuwkerk PT Burger MP	2011	B JOG2011，118，11：	1
17	The buccl mucosal graft for urethral restruction: a preliminary report显示文摘	Burger RA Muller SC ElDamanhoury H	1992	J Urol1992，147，3：	1
18	Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies显示文摘	Burger RA	2010	J Gynecol Oncol2010，21，1：	1
19	Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix:a gynecologic oncology group study 显示文摘	Monk B J Sill MW Burger RA	2009	J Clin Oncol2009，27，7：	1
20	Phase Ⅱ trim of bev- acizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer:a Gynecologic Oncology Group Study显示文摘	Burger RA Sill MW Monk B J	2007	J Clin Oncol2007，25，33：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示